Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dynamic Tumor Resistance”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Early research (Phase 1)Ended earlyNCT01489319
What this trial is testing

Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS)

Who this might be right for
Polycystic Ovary Syndrome
Indiana University 47
Not applicableLooking for participantsNCT06545994
What this trial is testing

A Prospective Cohort Study on the Serum Kisspeptin Levels Throughout Pregnancy in PCOS

Who this might be right for
Polycystic Ovary SyndromePregnancy Complications
Fudan University 180
Not applicableNot Yet RecruitingNCT06136377
What this trial is testing

Evaluation of the Concordance Between Pre-therapy Dosimetry Performed From 68Ga-PSMA-11 Dynamic PET and Post-treatment Dosimetry of 177Lu-PSMA-617 Vectorized Internal Radiotherapy in Patients With Metastatic Prostate Cancer Resistant to Hormonal Castration.

Who this might be right for
Patients With Metastatic Castration-resistant Prostate Cancer
Centre Georges Francois Leclerc 35
Early research (Phase 1)Study completedNCT00958477
What this trial is testing

Determine the Safety, Tolerability, Pharmacokinetics and Dynamic Effects of Different Doses of the Study Drug EMD 525797 in Prostate Cancer

Who this might be right for
Prostate CancerBone Metastases
Merck KGaA, Darmstadt, Germany 26
Testing effectiveness (Phase 2)Study completedNCT03227926
What this trial is testing

Rechallenge With Panitumumab Driven by RAS Dynamic of Resistance

Who this might be right for
Colorectal Cancer
Fondazione del Piemonte per l'Oncologia 32
Not applicableUnknownNCT04203095
What this trial is testing

Chromosomal Instability as a Surrogate Biomarker of Drug Resistance in Immunotherapy for Lung Cancer Patients

Who this might be right for
Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02703623
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
M.D. Anderson Cancer Center 196
Testing effectiveness (Phase 2)Looking for participantsNCT06378866
What this trial is testing

Stereotactic Body Radiation Therapy Plus Immediate or Delayed Androgen Receptor Pathway Inhibitor and Androgen Deprivation Therapy or Salvage Radiation Therapy for the Treatment of Prostate Cancer, DIVINE Trial

Who this might be right for
Recurrent Castration-Sensitive Prostate CarcinomaRecurrent Prostate CancerCastration-resistant Prostate Cancer+1 more
Mayo Clinic 532
Very early researchNot Yet RecruitingNCT07318389
What this trial is testing

ASCEND-CRC: Profiling and Targeting Dynamic Tumor Resistance in Patients With Metastatic Colorectal Cancer

Who this might be right for
Dynamic Tumor ResistanceMetastatic Colorectal Cancer
M.D. Anderson Cancer Center 100